SCHEMBL1707944

SCHEMBL1707944

CC(=O)O[C@@H]1COc2cc(N[C@@H]3COc4c3cccc4-n3c(C)nc4ccccc43)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.32
NTRK1 P04629 1/20 0.32
NTRK2 Q16620 1/20 0.32
PIK3CD O00329 3/20 0.31
PIK3CA P42336 3/20 0.31
PIK3CB P42338 3/20 0.31
MTOR P42345 3/20 0.31
PIK3CG P48736 3/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1708399 1.00 TSHR (0.38) TSHRMAPK1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL1708112 1.00 TSHR (0.38) TSHRMAPK1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL1708166 0.92 LMNA (0.36) TSHRMAPK1SMN1; SMN2ALDH1A1MAPT
SCHEMBL1707942 0.92 NTRK1 (0.36) TSHRMAPK1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL1708168 0.92 NTRK1 (0.36) TSHRMAPK1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL1708395 0.91 MAPT (0.32) TSHRMAPK1SMN1; SMN2ALDH1A1MAPT
SCHEMBL1708287 0.91 MAPT (0.32) TSHRMAPK1SMN1; SMN2ALDH1A1MAPT
SCHEMBL1708425 0.91 NTRK1 (0.36) TSHRMAPK1L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL1708628 0.91 MAPT (0.32) TSHRMAPK1SMN1; SMN2ALDH1A1MAPT
SCHEMBL1708091 0.90 ADORA2B (0.31) TSHRMAPK1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440541-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2012-04-18 EP disclosed
WO-2010143733-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-16 WO disclosed